39 related articles for article (PubMed ID: 29144570)
1. LncAPC drives Wnt/β-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition.
Fu X; Lin J; Qin F; Yang Z; Ding Y; Zhang Y; Han L; Zhu X; Zhang Q
Mol Carcinog; 2018 Mar; 57(3):408-418. PubMed ID: 29144570
[TBL] [Abstract][Full Text] [Related]
2. LncMAPK6 drives MAPK6 expression and liver TIC self-renewal.
Huang G; Jiang H; He Y; Lin Y; Xia W; Luo Y; Liang M; Shi B; Zhou X; Jian Z
J Exp Clin Cancer Res; 2018 May; 37(1):105. PubMed ID: 29764463
[TBL] [Abstract][Full Text] [Related]
3. lncRNA SNHG9 enhances liver cancer stem cell self-renewal and tumorigenicity by negatively regulating PTEN expression via recruiting EZH2.
Yang S; Ruan X; Hu B; Tu J; Cai H
Cell Tissue Res; 2023 Dec; 394(3):441-453. PubMed ID: 37851112
[TBL] [Abstract][Full Text] [Related]
4. Identification of cis-HOX-HOXC10 axis as a therapeutic target for colorectal tumor-initiating cells without APC mutations.
Chen Z; Wu J; Liu B; Zhang G; Wang Z; Zhang L; Wang K; Fan Z; Zhu P
Cell Rep; 2021 Jul; 36(4):109431. PubMed ID: 34320348
[TBL] [Abstract][Full Text] [Related]
5. β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.
Nakagawa C; Kadlera Nagaraj M; Hernandez JC; Uthay Kumar DB; Shukla V; Machida R; Schüttrumpf J; Sher L; Farci P; Mishra L; Tahara SM; Ou JJ; Machida K
Front Immunol; 2023; 14():1204907. PubMed ID: 37744383
[TBL] [Abstract][Full Text] [Related]
6. Global increase of p16INK4a in APC-deficient mouse liver drives clonal growth of p16INK4a-negative tumors.
Ueberham E; Glöckner P; Göhler C; Straub BK; Teupser D; Schönig K; Braeuning A; Höhn AK; Jerchow B; Birchmeier W; Gaunitz F; Arendt T; Sansom O; Gebhardt R; Ueberham U
Mol Cancer Res; 2015 Feb; 13(2):239-49. PubMed ID: 25270420
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression.
Deng Y; Li M; Zhuo M; Guo P; Chen Q; Mo P; Li W; Yu C
J Biol Chem; 2021; 296():100121. PubMed ID: 33434575
[TBL] [Abstract][Full Text] [Related]
8. Telomere dysfunction alters intestinal stem cell dynamics to promote cancer.
LaBella KA; Hsu WH; Li J; Qi Y; Liu Y; Liu J; Wu CC; Liu Y; Song Z; Lin Y; Blecher JM; Jiang S; Shang X; Han J; Spring DJ; Zhang J; Xia Y; DePinho RA
Dev Cell; 2024 Jun; 59(11):1475-1486.e5. PubMed ID: 38574731
[TBL] [Abstract][Full Text] [Related]
9. Proteins and Molecular Pathways Relevant for the Malignant Properties of Tumor-Initiating Pancreatic Cancer Cells.
Samonig L; Loipetzberger A; Blöchl C; Rurik M; Kohlbacher O; Aberger F; Huber CG
Cells; 2020 Jun; 9(6):. PubMed ID: 32503348
[TBL] [Abstract][Full Text] [Related]
10. Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition.
Mitra R; Chen X; Greenawalt EJ; Maulik U; Jiang W; Zhao Z; Eischen CM
Nat Commun; 2017 Nov; 8(1):1604. PubMed ID: 29150601
[TBL] [Abstract][Full Text] [Related]
11. Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner.
Fu X; Zhu X; Qin F; Zhang Y; Lin J; Ding Y; Yang Z; Shang Y; Wang L; Zhang Q; Gao Q
Mol Cancer; 2018 Mar; 17(1):73. PubMed ID: 29540185
[TBL] [Abstract][Full Text] [Related]
12.
Li X; Li M; Chen J; Dai H; Wang L; Xiong Y; Zhong Y; Zhang L
Oncotarget; 2017 Nov; 8(61):103785-103796. PubMed ID: 29262600
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target.
Zhao Z; Cui T; Wei F; Zhou Z; Sun Y; Gao C; Xu X; Zhang H
Front Oncol; 2024; 14():1367364. PubMed ID: 38634048
[TBL] [Abstract][Full Text] [Related]
14. WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities.
Gajos-Michniewicz A; Czyz M
Genes Dis; 2024 Mar; 11(2):727-746. PubMed ID: 37692481
[TBL] [Abstract][Full Text] [Related]
15. Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.
Fang X; Yan Q; Liu S; Guan XY
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293184
[TBL] [Abstract][Full Text] [Related]
16. Retraction Note: LncMAPK6 drives MAPK6 expressionand liver TIC self-renewal.
Huang G; Jiang H; He Y; Lin Y; Xia W; Luo Y; Liang M; Shi B; Zhou X; Jian Z
J Exp Clin Cancer Res; 2022 Oct; 41(1):308. PubMed ID: 36266670
[No Abstract] [Full Text] [Related]
17. Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2.
Lachat C; Boyer-Guittaut M; Peixoto P; Hervouet E
Epigenomes; 2018 Dec; 3(1):. PubMed ID: 34991274
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
19.
Zhu L; Li X; Yuan Y; Dong C; Yang M
Front Oncol; 2021; 11():653222. PubMed ID: 33968756
[TBL] [Abstract][Full Text] [Related]
20. EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas.
Lachat C; Bruyère D; Etcheverry A; Aubry M; Mosser J; Warda W; Herfs M; Hendrick E; Ferrand C; Borg C; Delage-Mourroux R; Feugeas JP; Guittaut M; Hervouet E; Peixoto P
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
